Vivanza Biosciences Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 41.206 million compared to INR 31.656 million a year ago. Net income was INR 1.657 million compared to net loss of INR 1.657 million a year ago. Basic earnings per share from continuing operations was INR 0.41 compared to basic loss per share from continuing operations of INR 0.41 a year ago. For the nine months, total revenue was INR 73.849 million compared to INR 36.933 million a year ago. Net income was INR 2.035 million compared to net loss of INR 6.934 million a year ago. Basic earnings per share from continuing operations was INR 0.51 compared to basic loss per share from continuing operations of INR 1.73 a year ago.